Structure activity evaluation and computational analysis identify potent, novel 3-benzylidene chroman-4-one analogs with anti-fungal, anti-oxidant, and anti-cancer activities.
Benzylidene chromanones
anticancer
antifungal
antioxidant
computational analysis
structure activity relationship
Journal
Drug development and industrial pharmacy
ISSN: 1520-5762
Titre abrégé: Drug Dev Ind Pharm
Pays: England
ID NLM: 7802620
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
pubmed:
3
11
2021
medline:
27
4
2022
entrez:
2
11
2021
Statut:
ppublish
Résumé
3-Benzylidene chroman-4-ones share close homology with naturally occurring bioactive compounds. This study evaluated the antifungal, antioxidant, and anticancer activities of novel 3-benzylidene chromanone analogs with respect to their structure-activity relationships. Compounds Out of the twenty compounds screened, compounds In summary, our study identified potential analogs of 3-benzylidene chroman-4-one molecules with excellent anti-fungal, anti-oxidant, and anticancer activities which demand further research for drug developments.
Identifiants
pubmed: 34726982
doi: 10.1080/03639045.2021.2001489
doi:
Substances chimiques
Antineoplastic Agents
0
Antioxidants
0
Oxidants
0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM